Weeks after ordering staff back to the office, the U.S. Food and Drug Administration (FDA) is now letting some employees work from home again. The move follows major staff cuts and resignations that threaten the agency’s ability to approve new medicines among other basic functions, The Associated Press reported. An internal email shared with staff… read on > read on >







